首页> 外国专利> N-angiotensin- (1-7) peptide (arg7) and pharmaceutical compositions for disease treatment

N-angiotensin- (1-7) peptide (arg7) and pharmaceutical compositions for disease treatment

机译:N-血管紧张素-(1-7)肽(arg7)和用于疾病治疗的药物组合物

摘要

N-angiotensin (1-7) peptide (arg °) and pharmaceutical compositions for treating diseases. The present invention consists of the (arg0) n-angiotensin- (1-7) 5 [(arg0) n-ang- (1-7)] peptide, where n is 1 to 10 (sf0 id n01, where xaa represents a variation (1-10 amino acids 1-arg), which is produced by inserting at least one arginine amino acid into the amino-terminal position of ang- (1-7), as well as pharmaceutical compositions containing this peptide and their use for treatment or prevention of diseases or disorders that are due to or have reduced nitric oxide production, with non-imitating cardiopulmonary and hepatic disorders, vasculopathies, metabolic, neural, genitourinary tract, musculoskeletal, renal, cutaneous, alopecia or tumors . The peptide is capable of causing, for example, dilation of aortic and mesenteric vessels, reduction of mean arterial pressure, decrease in body weight gain, blockade of development of visceral adiposity, reduction of serum and hepatic cholesterol levels, normalization of intolerance to glucose and insulin resistance and anti-proliferative effect. The (arg0) -ang- (1-7) peptide may optionally be associated with a carrier system or controlled drug delivery system.
机译:N-血管紧张素(1-7)肽(arg°)和用于治疗疾病的药物组合物。本发明由(arg0)n-血管紧张素-(1-7)5 [(arg0)n-angang-(1-7)]肽组成,其中n为1至10(sf0 id n01,其中xaa代表a变异(1-10个氨基酸1-arg),其是通过将至少一个精氨酸氨基酸插入ang-(1-7)的氨基末端位置而产生的,以及含有该肽的药物组合物及其用途一氧化氮产生或减少的疾病或病症的治疗或预防,具有非模仿性心肺和肝脏疾病,血管病变,代谢,神经,泌尿生殖道,肌肉骨骼,肾脏,皮肤,脱发或肿瘤。引起例如主动脉和肠系膜血管扩张,平均动脉压降低,体重增加降低,内脏脂肪形成的阻断,血清和肝胆固醇水平降低,对葡萄糖和胰岛素抵抗的不耐受性恢复正常和抗增殖的效果。 (arg0)-ang-(1-7)肽可以任选地与载体系统或受控药物递送系统相关。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号